MedPath

the study is to evaluate safety and performance of Eye Preparations - Distilled Witch Hazel eye wash

Phase 4
Completed
Conditions
Health Condition 1: H28- Cataract in diseases classified elsewhere
Registration Number
CTRI/2022/07/043857
Lead Sponsor
Stericon Pharma Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
72
Inclusion Criteria

At the time of screening and usage of the product all subjects must meet the following criteria for inclusion into the study and the subjects will receive the prescribed eye wash from the PI/CO-PI by a medical practitioner. The inclusion criteria for the subjects for this study are as follows:

-Subjects who experience irritation, soreness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment

Exclusion Criteria

The below Subjects are excluded from the study:

-Subjects who are not willing to participate in the study

-Anyone with known allergic reaction to Eye wash with Herbal extract/Distilled witch Hazel Eye Wash

-Subjects with allergic reaction to any eye medication or any existing eye infection

-Subjects undergone recent (6 weeks) cataract surgery who are on other eye medications

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.